Location History:
- Vienna, AT (1998 - 2001)
- Milan, IT (2002 - 2004)
Company Filing History:
Years Active: 1998-2004
Title: Susanna Chiocca: Innovator in Gene Therapy and Vaccine Development
Introduction
Susanna Chiocca is a prominent inventor based in Milan, Italy. She has made significant contributions to the fields of gene therapy and vaccine development, particularly through her work with the Chicken Embryo Lethal (CELO) virus. With a total of 4 patents to her name, Chiocca's innovations are paving the way for advancements in medical science.
Latest Patents
Chiocca's latest patents include groundbreaking work on the Chicken Embryo Lethal (CELO) virus. This virus, obtained through in vitro manipulation of a plasmid-cloned CELO virus DNA, is suitable for the production of vectors for gene therapy. It also serves as a vaccine against infectious diseases in both humans and animals, particularly birds. Another notable patent is the Chicken Embryo Lethal Orphan (CELO) virus, which shares similar applications and benefits.
Career Highlights
Chiocca is currently employed at Boehringer Ingelheim International GmbH, where she continues to innovate and contribute to the field of biotechnology. Her work has garnered attention for its potential to improve health outcomes through advanced therapeutic methods.
Collaborations
Throughout her career, Chiocca has collaborated with esteemed colleagues such as Matthew Cotten and Gotthold Schaffner. These partnerships have further enhanced her research and development efforts in the biotechnology sector.
Conclusion
Susanna Chiocca's contributions to gene therapy and vaccine development highlight her as a leading inventor in her field. Her innovative work with the CELO virus demonstrates the potential for significant advancements in medical science.